Navigation Links
PRC Clinical to Host ClinPulse Event On “The Sponsor-Site Relationship"
Date:3/16/2017

PRC Clinical is organizing a ClinPulse panel discussion and networking event on Wednesday, March 29th, 2017 from 6pm to 8.30pm PST at Dominic’s in South San Francisco. Clinical trial industry leaders and experts will discuss the topic: “The Sponsor-Site Relationship: Winning Strategies & Ideas.” Food and drinks will be served.

The panel will be comprised of clinical trial executives, industry leaders, and technology experts:

  • Lillian Lee, PMP, Senior Manager, Clinical Operations, BioMarin
  • Hugh Levaux, Ph.D., Founder & CEO, Protocol First
  • David Selam, CEO, Clinical Trial Investigators
  • Peter St.Wecker, Ph.D., Director, Clinical Operations, Zogenix
  • Moderated by Colleen Hoke, President & CEO, Objective Clinical

In a competitive market, where being the first to bring a new drug to the market can save millions, optimizing clinical trials is critical. In particular, establishing and maintaining good relationships with clinical research sites and investigators, who lead clinical studies on the ground, is essential for sponsors. Without it, it can be more challenging to collect high quality data, to optimize patient enrollment or even to be alerted and proactive in case of difficulties.

Sponsors who understand the needs of research sites and engage with them early can save a considerable amount of time, frustration, and money. However, investigating site performance ahead of time can be highly variable and unpredictable. Maintaining good relationships across disparate teams and places under the pressure of the study can also be challenging. This installment of ClinPulse by PRC Clinical will present tangible ideas, tools, practices, and proven strategies to help sponsors establish fruitful relationships with sites to work efficiently, prevent issues, and ultimately deliver better results for patients.

  • What are the top criteria for site selection and how to avoid mistakes?
  • How to anticipate and resolve frustrations and create a more efficient communication?
  • How to collect feedback and suggestions from sites and create a two-way communication channel?
  • How to avoid the screen effect of CROs and better work as an integrated sponsor/CRO/sites team?
  • How to avoid a crisis with clinical research sites (or solve one)?
  • How to plan for your future studies and create long-term relationships?

This panel discussion is ideal for:

  • Clinical Operations teams
  • Clinical Study Managers
  • Clinical Research Associates
  • Investigators and Sites
  • Anyone interested in improving sponsor-site relationships

This networking and panel discussion event is organized by PRC Clinical in partnership with the ClinOps Toolkit, an online platform gathering, resources, information, and advice for clinical trial professionals. This event is the fifth session of the ClinPulse Expert Event Series sponsored by PRC Clinical. ClinPulse is an expert networking and panel discussion event for pharmaceutical, biotech, and medical device professionals in the San Francisco Bay Area. The ClinPulse Expert Event Series gathers experts and leaders from the healthcare industry and beyond to discuss the future of clinical trials. Please join us for this intimate and insightful event by registering for free at prcclinical.com/clinpulse

About PRC Clinical

PRC Clinical is the CRO of choice for many pharmaceutical, biotech and regenerative medicine developers worldwide, offering a next-level clinical trial management experience. Our innovative approach to executing studies merges our high-touch human element with high-tech tools, extensive experience and deep knowledge – far exceeding the level of service offered by large CROs. We offer full Clinical Trial Management services including Clinical Project Management, Site Monitoring, Quality Assurance, Drug Safety, Payment Services, Biostatistics, Data Management, Regulatory Strategies, and Site Selection and Enrollment. PRC clinical has significant CRO experience in a wide range of therapeutic areas: Regenerative Medicine, CNS, Neurology, ALS, Parkinson’s, Pain, GI, Device, Anti-infective, Cardiovascular, Pulmonary, Oncology, Endocrine, and Stem cells. Call us at 1-877-519-6001, or email info(at)prcclinical(dot)com.

Read the full story at http://www.prweb.com/releases/2017/03/prweb14155308.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
2. Positive Clinical Breast Cancer Data Presented for NuView’s Molecular Imaging Biomarker NLS-VPAC1
3. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
4. Ingenuity Systems and GeneInsight to Deliver an Interpretation and Reporting Workflow Solution to Clinical Laboratories
5. Greenwood Genetic Center Selects Cartagenia BENCHlab NGS, CNV Solutions for Clinical Data Analysis
6. Clinical Trials and Medical Research in Texas Create Jobs and Save Lives
7. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
8. Medical University of South Carolina Selects Elseviers Interdisciplinary Care Planning and Clinical Documentation Solution
9. Clinilabs Launches Research Volunteer Authentication Initiative Choosing Verified Clinical Trials to Stop Dual Enrollment in Clinical Trials
10. ISPE Releases New Guidance for Standardizing Use of Booklet Labels in Global Clinical Trials
11. Trigemina Receives ISP Approval of Clinical Study Protocol for TI-001 Phase 2 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
(Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives ... the award for Excellence in Volunteer Experience from US2020. , US2020’s mission is ...
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:3/24/2017)... March 24, 2017 The Controller General of Immigration ... Abdulla Algeen have received the prestigious international IAIR Award for ... Continue Reading ... ... Deputy Controller Abdulla Algeen (small picture on the right) have received the ...
(Date:3/23/2017)... India , March 23, 2017 The report "Gesture ... Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, ... at a CAGR of 29.63% between 2017 and 2022. ... ... ...
(Date:3/22/2017)... 21, 2017   Neurotechnology , a provider ... today announced the release of the SentiVeillance ... improved facial recognition using up to 10 surveillance, ... computer. The new version uses deep neural-network-based facial ... it utilizes a Graphing Processing Unit (GPU) for ...
Breaking Biology News(10 mins):